Home›Companies›Healthcare›Zyppah

Zyppah, Inc.

Sells anti-snoring mouthpieces to adults who snore.

Updated Nov 19, 2026·Latest SEC filing Sep 9, 2024·Suggest an edit

About Zyppah

Zyppah is a private company based in Reno, Nevada. It has reported $185,000 raised in three offerings on Form D since July 2016. Its chief executive is Lawrence Biggs.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 26, 2024Sep 9, 2024$60,000of $5.0M target2$30,000EquityRule 506(c)Form D ↗
Apr 17, 2023Jun 22, 2023amended Nov 7, 2023$125,000target not set13$9,615EquityRule 506(b)Form D/A ↗1 earlier filing
Not yetJul 18, 2016$0of $4.5M target0—EquityRule 506(c)Form D ↗
Total, three offerings$185,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Zyppah's Form D filed Sep 9, 2024.

Jonathan Greenburg
Jonathan Greenburg
Chairman
On every Form D that Zyppah has filed: 4 filings, from Jul 18, 2016 to Sep 9, 2024.
Lawrence Biggs
Lawrence Biggs
CEO and director
First appears on the amended Form D that Zyppah filed on November 7, 2023; on 2 of its 4 filings.

Earlier filings also listed

  • Owen Gonzales · executive officer
    Last listed on the Form D that Zyppah filed on July 18, 2016; on 1 of its 4 filings.

Sources

  1. SECZyppah, Inc. Form D, filed Jun 22, 2023
  2. SECZyppah, Inc. filing history
  3. CompanyInvest in Zyppah
  4. PressZyppah anti-snoring device clearance